Trexquant Investment’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-92,100
Closed -$5.9M 1490
2018
Q4
$5.9M Buy
92,100
+60,422
+191% +$4.46M 0.37% 49
2018
Q3
$2.83M Sell
31,678
-28,725
-48% -$2.54M 0.21% 142
2018
Q2
$4.8M Buy
60,403
+42,403
+236% +$3.52M 0.33% 77
2018
Q1
$1.61M Sell
18,000
-9,840
-35% -$945K 0.11% 293
2017
Q4
$2.9M Buy
+27,840
New +$3.14M 0.32% 52
2017
Q1
Sell
-5,000
Closed -$579K 1491
2016
Q4
$579K Buy
5,000
+2,621
+110% +$292K 0.09% 376
2016
Q3
$249K Sell
2,379
-17,821
-88% -$1.93M 0.06% 553
2016
Q2
$1.99M Buy
20,200
+15,200
+304% +$1.57M 0.26% 97
2016
Q1
$500K Buy
+5,000
New +$515K 0.06% 545
2015
Q2
Sell
-14,400
Closed -$1.66M 1447
2015
Q1
$1.66M Buy
+14,400
New +$1.72M 0.17% 170

Other funds holding CELG

Trexquant Investment's CELG Position: Q1 2019 in Review

Trexquant Investment sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 92,100 shares — an estimated $5.9M sold.

Trexquant Investment first reported a position in CELG in Q1 2015 and held it in 10 quarters. The position peaked at $5.9M in Q4 2018. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Trexquant Investment reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Trexquant Investment sold 92,100 Celgene Corp shares in Q1 2019, an estimated $5.9M.
  • Trexquant Investment first reported a position in Celgene Corp in Q1 2015 and held it in 10 quarters.
  • Trexquant Investment's Celgene Corp position peaked at $5.9M in Q4 2018.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Trexquant Investment's 13F filing for Q1 2019, filed 13 May 2019.